These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36326552)

  • 1. Induction of Type I Diabetes Mellitus in Beagle Dogs Using Alloxan and Streptozotocin.
    Araujo J; Paradis A; Mendes J; Petrik S; de Rivera C
    Curr Protoc; 2022 Nov; 2(11):e580. PubMed ID: 36326552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro.
    Gai W; Schott-Ohly P; Schulte im Walde S; Gleichmann H
    Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):29-37. PubMed ID: 14758569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Streptozocin- and alloxan-induced H2O2 generation and DNA fragmentation in pancreatic islets. H2O2 as mediator for DNA fragmentation.
    Takasu N; Komiya I; Asawa T; Nagasawa Y; Yamada T
    Diabetes; 1991 Sep; 40(9):1141-5. PubMed ID: 1834504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated Low-Dose Streptozotocin and Alloxan Induced Long-Term and Stable Type 1 Diabetes Model in Beagle Dogs.
    Han Q; Sun J; Xie W; Bai Y; Wang S; Huang J; Zhou S; Li Q; Zhang H; Tang Z
    Biomed Res Int; 2022; 2022():5422287. PubMed ID: 35978645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemically induced (streptozotocin-alloxan) diabetes mellitus in the dog. Biochemical and ultrastructural studies.
    Black HE; Rosenblum IY; Capen CC
    Am J Pathol; 1980 Feb; 98(2):295-310. PubMed ID: 6444498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotoxicological effects of streptozotocin and alloxan: in vitro and in vivo studies.
    Diab RA; Fares M; Abedi-Valugerdi M; Kumagai-Braesch M; Holgersson J; Hassan M
    Immunol Lett; 2015 Feb; 163(2):193-8. PubMed ID: 25573197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The direct effects of streptozotocin and alloxan on contractile function in rat heart.
    Salem KA; Kosanovic M; Qureshi A; Ljubisavljevic M; Howarth FC
    Pharmacol Res; 2009 Apr; 59(4):235-41. PubMed ID: 19429464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular target structures in alloxan-induced diabetes in mice.
    im Walde SS; Dohle C; Schott-Ohly P; Gleichmann H
    Life Sci; 2002 Aug; 71(14):1681-94. PubMed ID: 12137914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endangered Lymphocytes: The Effects of Alloxan and Streptozotocin on Immune Cells in Type 1 Induced Diabetes.
    Queiroz LAD; Assis JB; Guimarães JPT; Sousa ESA; Milhomem AC; Sunahara KKS; Sá-Nunes A; Martins JO
    Mediators Inflamm; 2021; 2021():9940009. PubMed ID: 34712101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemically induced (streptozotocin-alloxan) diabetes mellitus in dogs].
    Liu S; Wang W; Luo XM; Ye B
    Hunan Yi Ke Da Xue Xue Bao; 2000 Apr; 25(2):125-8. PubMed ID: 12212196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxin-induced IDDM (insulin dependent diabetes mellitus) in the musk shrew.
    Ohno T; Kitoh J; Yamashita K; Ichikawa Y; Horio F; Terada M; Tanaka S; Namikawa T
    Life Sci; 1998; 63(6):455-62. PubMed ID: 9718069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Streptozotocin and alloxan produce alterations in rat brain monoamines independently of pancreatic beta cells destruction.
    Lacković Z; Salković M
    Life Sci; 1990; 46(1):49-54. PubMed ID: 1688991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of alloxan/streptozotocin diabetes in dogs: a revised experimental technique.
    Anderson HR; Stitt AW; Gardiner TA; Lloyd SJ; Archer DB
    Lab Anim; 1993 Jul; 27(3):281-5. PubMed ID: 8366676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model of Streptozotocin-nicotinamide Induced Type 2 Diabetes: a Comparative Review.
    Rais N; Ved A; Ahmad R; Parveen K; Gautam GK; Bari DG; Shukla KS; Gaur R; Singh AP
    Curr Diabetes Rev; 2022; 18(8):e171121198001. PubMed ID: 34789130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the diabetogenic drugs alloxan and streptozotocin as models for the study of immune defects in diabetic mice.
    Gaulton GN; Schwartz JL; Eardley DD
    Diabetologia; 1985 Oct; 28(10):769-75. PubMed ID: 2933286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-phenyl-tert-butylnitrone (PBN) inhibits NFkappaB activation offering protection against chemically induced diabetes.
    Ho E; Chen G; Bray TM
    Free Radic Biol Med; 2000 Feb; 28(4):604-14. PubMed ID: 10719242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental models in research of the pathomechanism of diabetes mellitus].
    Pusztai P; Prechl J; Somogyi A; Szaleczky E; Fehér J
    Orv Hetil; 1996 Aug; 137(34):1865-9. PubMed ID: 8927340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Streptozotocin-Induced Diabetic Models in Mice and Rats.
    Furman BL
    Curr Protoc; 2021 Apr; 1(4):e78. PubMed ID: 33905609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PUFAs, BDNF and lipoxin A4 inhibit chemical-induced cytotoxicity of RIN5F cells in vitro and streptozotocin-induced type 2 diabetes mellitus in vivo.
    Bathina S; Das UN
    Lipids Health Dis; 2019 Dec; 18(1):214. PubMed ID: 31823816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA strand breaks and poly(ADP-ribose) synthetase activation in pancreatic islets--a new aspect to development of insulin-dependent diabetes and pancreatic B-cell tumors.
    Okamoto H; Yamamoto H
    Princess Takamatsu Symp; 1983; 13():297-308. PubMed ID: 6317640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.